Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
A leader in in-vivo CRISPR gene editing with two Phase 3 trials underway. The ATTR market...
— Waystone Management Company (IE) Limited
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Intellia Therapeutics
No other institutional pitches found for this ticker yet.
More institutional theses from Contrarius Global Equity Fund
Paramount represents a deeply discounted contrarian play. Despite market concerns...
Grab maintains overwhelming dominance in Southeast Asian mobility and food delivery, with its nearest competitors holding minor fractions of the market. Having significantly reduced...
Just Eat Takeaway is the dominant food delivery player in Northern Europe, the UK, and several other international regions. Management has driven...